Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Saturn Oil & Gas Inc. Announces its First Development of Cardium Wells at Brazeau and Continued Successful Development (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum SCYNEXIS Inc SCYX

Healthcare
SCYNEXIS, Inc. is a biotechnology company. It is pioneering medicine to overcome and prevent difficult-to-treat and drug-resistant infections. It develops antifungal platform fungerps, a novel class of antifungal agents called triterpenoids, that are structurally distinct glucan synthase inhibitors and have generally shown in vitro and in vivo activity against a range of human fungal pathogens,... see more

NDAQ:SCYX - Post Discussion

SCYNEXIS Inc > Drug just got approved! :)
View:
Post by JonathanJSmith on Jun 02, 2021 7:39am

Drug just got approved! :)

https://finance.yahoo.com/news/scynexis-announces-fda-approval-brexafemme-113000221.html

Cheers,

JJ
Comment by Kipper22 on Jun 02, 2021 11:06am
Seriously!? Approved and it goes down... Wtf
Comment by JonathanJSmith on Jun 02, 2021 3:58pm
Yeah, I wasn't expecting this kind of reaction either. The next few weeks will tell the tale; the approval information needs to be absorbed. Based on the CC today, I inferred that an EMEA partnership will be forthcoming shortly. As Tags put it: "stay tuned".  :) I haven't sold one share or option yet and don't intend to for the foreseeable future (unless something ...more  
Comment by dmacd on Aug 17, 2021 2:35pm
Wow. These biopharma stocks are truly in show me stage for valuation. Great opportunity for those with high conviction (like me) to load up way more than you thought you could. Sales will start slow since it takes some time to gain momentum but imagine if sales take off faster than the market expects ... at any rate I am sitting back on a load of core shares and will buy a trading position if it ...more  
SCYNEXIS Inc